October 07, 2024
Trending Now
1
FDA Approves Cobenfy for Schizophrenia
2
Parkinson's Drug Achieves Main Goal in Late-Stage Trial
3
FDA Greenlights New Heart Disease Diagnostic Drug
4
FDA Approves Dupilumab for ‘Smoker's Lung'
5
Aspirin, Heparin May Boost Outcomes in Recurrent Pregnancy Loss
6
Diabetes Screening Practices in Women With PCOS
Conference Coverage
2024 ASCO Quality Care Symposium
2024 IASLC WCLC
Clinical Guidelines
View MoreOctober 01, 2024
Clinical Trial Update October 2024
Commentary & Perspectives
View MoreOctober 07, 2024
Edible Labeling: Patient Information in JAMA 'Problematic'
October 07, 2024
FDA's Pulse Oximeter Rules Unlikely to End Racial Bias
October 03, 2024
Experts Urged Caution on Mouth Taping Trend
October 01, 2024
PAH Study Critique: Selexipag's Real-World Impact
FDA & Government News
View MoreOctober 07, 2024
Florida Physician Arrested for Murder in Pill Mill Operation
October 07, 2024
U.S. Duo Wins Nobel for MicroRNA Discovery
October 04, 2024
Infant RSV Drug Plant Violated FDA Rules, Docs Show
October 04, 2024
Regulator Reviews Hair-Loss Drugs Over Suicide Risk
Business Management
View MoreOctober 01, 2024
Win the Battle for Positive Change
October 01, 2024
Viewpoint From the Editor: Another Year Almost Over – How Did We Do?
September 30, 2024
More Females Entering High-Paying Specialties
September 27, 2024